The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

In efforts to boost innovation, pharma and med-tech sectors in India seek a 10% allocation from the National Research Fund, ...

The Indian pharmaceutical market (IPM) has returned to negative volume growth this Q3FY25 after two consecutive quarters of ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

Zlata Pharma LLP hosted a memorable event to mark the launch of its new wellness product range, marking a significant ...

Health Care Without Harm aims to transform global healthcare to minimize its environmental impact and promote sustainability ...

The Indian pharma industry is at a juncture where digital transformation is sweeping the healthcare landscape. - Issue Date: ...

The government has proposed extending the compliance deadline for revised Schedule M norms for pharmaceutical manufacturing.

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research ...

pharmaphorum looks at its evolution over the centuries. The roots of the pharmaceutical industry lie back with the apothecaries and pharmacies that offered traditional remedies as far back as the ...

The pharmaceutical industry is often described as ‘conservative’ and those making the blockbuster drugs do experience the same slow pace of change as other big companies, supercharged (or slow ...